HPIA
ABBV icon

Hamilton Point Investment Advisors’s AbbVie ABBV Stock Holding History

Hamilton Point Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Hold
6,155
– – 0.22% 67
2026
Q1 		$1.34M Sell
6,155
-63
-1% -$14K 0.21% 69
2025
Q4 		$1.42M Buy
6,218
+84
+1% +$19.1K 0.22% 66
2025
Q3 		$1.42M Buy
6,134
+1
+0% +$204 0.22% 64
2025
Q2 		$1.14M Sell
6,133
-12
-0.2% -$2.23K 0.19% 70
2025
Q1 		$1.29M Sell
6,145
-11
-0.2% -$2.14K 0.23% 66
2024
Q4 		$1.09M Buy
6,156
+872
+17% +$160K 0.19% 67
2024
Q3 		$1.04M Sell
5,284
-1,000
-16% -$187K 0.18% 69
2024
Q2 		$1.08M Sell
6,284
-204
-3% -$33.8K 0.2% 68
2024
Q1 		$1.18M Sell
6,488
-1,224
-16% -$211K 0.23% 70
2023
Q4 		$1.19M Buy
7,712
+970
+14% +$141K 0.24% 68
2023
Q3 		$1M Hold
6,742
– – 0.25% 68
2023
Q2 		$908K Hold
6,742
– – 0.22% 68
2023
Q1 		$1.07M Buy
6,742
+4,461
+196% +$682K 0.26% 64
2022
Q4 		$369K Buy
2,281
+13
+0.6% +$1.99K 0.1% 69
2022
Q3 		$304K Buy
+2,268
New +$325K 0.09% 72

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hamilton Point Investment Advisors's ABBV Position: Q2 2026 in Review

Hamilton Point Investment Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 6,155 shares worth $1.55M. The position accounts for 0.22% of the portfolio, ranked #67.

Hamilton Point Investment Advisors first reported a position in ABBV in Q3 2022 and has held it in 16 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hamilton Point Investment Advisors held 6,155 shares of AbbVie worth $1.55M as of Q2 2026.
  • Hamilton Point Investment Advisors left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.22% of Hamilton Point Investment Advisors's portfolio in Q2 2026, its #67 holding.
  • Hamilton Point Investment Advisors first reported a position in AbbVie in Q3 2022 and has held it in 16 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hamilton Point Investment Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.